This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Koreans' exposure to AI, GenAI both jump in 2024, survey shows

( March 31, 2025, 08:31 GMT | Official Statement) -- MLex Summary: The exposure of South Koreans to one or more types of artificial intelligence products and services has continued to increase rapidly, with the latest survey finding that 60.3 percent of the country’s population had experience with AI, according to the Ministry of Science and ICT. The ratio was up from 50.8 percent in 2023 and 42.4 percent in 2022, according to the ministry’s survey of about 60,000 people in the fourth quarter of 2024. In the same survey, 33.3 percent of the respondents said they had experience using generative AI products or services in 2024, nearly double the 17.6 percent in 2023. Searching for information topped the list of the main purposes for using generative AI, followed by receiving help while working on documents, and translating foreign languages, the ministry said. The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections